Search Results - "Verleden, Geert M."

Refine Results
  1. 1

    A new classification system for chronic lung allograft dysfunction by Verleden, Geert M., MD, PhD, Raghu, Ganesh, PhD, Meyer, Keith C., PhD, Glanville, Allan R., MBBS, MD, FRACP, Corris, Paul, MBBS, FRCP

    “…Although survival after lung transplantation has improved significantly during the last decade, chronic rejection is thought to be the major cause of late…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation by Verleden, Stijn E., PhD, Sacreas, Annelore, MSc, Vos, Robin, MD, PhD, Vanaudenaerde, Bart M., PhD, Verleden, Geert M., MD, PhD

    Published in Chest (01-07-2016)
    “…Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, causing significant morbidity and mortality in a majority of…”
    Get full text
    Journal Article
  6. 6

    An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome by MEYER, Keith C, RAGHU, Ganesh, VERLEDEN, Geert M, CORRIS, Paul A, AURORA, Paul, WILSON, Kevin C, BROZEK, Jan, GLANVILLE, Allan R

    Published in The European respiratory journal (01-12-2014)
    “…Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for…”
    Get full text
    Journal Article
  7. 7

    Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation by Verleden, Stijn E, Vanaudenaerde, Bart M, Emonds, Marie-Paul, Van Raemdonck, Dirk E, Neyrinck, Arne P, Verleden, Geert M, Vos, Robin

    Published in The European respiratory journal (01-11-2017)
    “…Donor-specific antibodies (DSAs) against human leukocyte antigen (HLA) are associated with chronic lung allograft dysfunction (CLAD) and mortality post lung…”
    Get full text
    Journal Article
  8. 8

    The pathogenesis of pulmonary fibrosis: a moving target by WUYTS, Wim A, AGOSTINI, Carlo, PRASSE, Antje, ROBALO-CORDEIRO, Carlos, VERBEKEN, Eric, VERSCHAKELEN, Johny A, WELLS, Athol U, VERIEDEN, Geert M, ANTONIOU, Katerina M, BOUROS, Demosthenes, CHAMBERS, Rachel C, COTTIN, Vincent, EGAN, Jim J, LAMBRECHT, Bart N, LORIES, Rik, PARFREY, Helen

    Published in The European respiratory journal (01-05-2013)
    “…Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is characterised by excessive matrix formation leading to destruction of the…”
    Get full text
    Journal Article
  9. 9

    Chronic lung allograft dysfunction phenotypes and treatment by Verleden, Stijn E, Vos, Robin, Vanaudenaerde, Bart M, Verleden, Geert M

    Published in Journal of thoracic disease (01-08-2017)
    “…Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lung transplantation. Given the clinical heterogeneity of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Current views on chronic rejection after lung transplantation by Verleden, Geert M, Vos, Robin, Vanaudenaerde, Bart, Dupont, Lieven, Yserbyt, Jonas, Van Raemdonck, Dirk, Verleden, Stijn

    Published in Transplant international (01-10-2015)
    “…Chronic lung allograft dysfunction (CLAD) was recently introduced as an overarching term mainly to classify patients with chronic rejection after lung…”
    Get more information
    Journal Article
  13. 13

    Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial by Ruttens, David, Verleden, Stijn E, Demeyer, Heleen, Van Raemdonck, Dirk E, Yserbyt, Jonas, Dupont, Lieven J, Vanaudenaerde, Bart M, Vos, Robin, Verleden, Geert M

    Published in PloS one (06-04-2018)
    “…Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report by Verfaillie, Saartje, Godinas, Laurent, Spriet, Isabel, Vos, Robin, Verleden, Geert M

    Published in BMC pulmonary medicine (27-03-2022)
    “…Variability in triazole plasma concentrations by drug interactions is well known. An interaction between voriconazole and flucloxacillin has already been…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Differential Cytokine, Chemokine and Growth Factor Expression in Phenotypes of Chronic Lung Allograft Dysfunction by Verleden, Stijn E, Ruttens, David, Vos, Robin, Vandermeulen, Elly, Moelants, Eva, Mortier, Anneleen, Van Raemdonck, Dirk E, Proost, Paul, Schols, Dominique, Verleden, Geert M, Vanaudenaerde, Bart M

    Published in Transplantation (01-01-2015)
    “…BACKGROUNDChronic lung allograft dysfunction is a heterogeneous entity limiting long-term survival after lung transplantation. Different clinical phenotypes…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The common rejection module in chronic rejection post lung transplantation by Sacreas, Annelore, Yang, Joshua Y C, Vanaudenaerde, Bart M, Sigdel, Tara K, Liberto, Juliane M, Damm, Izabella, Verleden, Geert M, Vos, Robin, Verleden, Stijn E, Sarwal, Minnie M

    Published in PloS one (05-10-2018)
    “…Recent studies suggest that similar injury mechanisms are in place across different solid organ transplants, resulting in the identification of a common…”
    Get full text
    Journal Article
  20. 20